FDA Inspection
Cipla LimitedCipla Limited – FDA Inspection, Aug 25, 2026
Record Details
This FDA Inspection record concerns Cipla Limited, with an inspection on August 25, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 8e984a05-d69e-4ebb-beb1-b0eca787a4ba
Inspection Facts
- Inspection number
- 1331746
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Cipla Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 17, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2017 | Not classified | Office of Inspections and Investigations | Generic Drug Evaluation |
| January 27, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Cipla Limited
- FDA Inspection 1198343 - 2023-02-17
- FDA Inspection 1094880 - 2019-05-17
- FDA Inspection 1048005 - 2018-04-13
- FDA Inspection 1019068 - 2017-06-23
- FDA Inspection 1007876 - 2017-01-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.